My hyaluronic acid story

2016-10-201 min read

Written and reviewed by Dr Bernard Hayot, ophthalmologist, RPPS 10003926226.

My hyaluronic acid story

In 1986 I learned of the work of the optician Waldemar Kita, who had just set up Cornéal, a company specialising in the design and manufacture of intraocular lenses for this delicate surgery.

Alongside ophthalmology, Cornéal gradually made its mark in aesthetic medicine with the production of high-quality hyaluronic acid: Juvéderm® and Surgiderm®.

As my interest in aesthetic medicine and anti-ageing treatments grew, so did my interest in using hyaluronic acid-based products in place of collagen. The risk of allergy was considerably reduced, as the product proved far better tolerated by the body. Being resorbable and biodegradable, it also had the advantage of preventing any long-lasting, irreversible mishap.

In 2006, Allergan, a pharmaceutical company whose flagship product was Botox, acquired the Cornéal laboratory, which specialised in injectable products for aesthetic medicine. Manufacturing and marketing took off in the 2000s.

As an Allergan reference physician myself, I was asked to test the product in the first cases of wrinkle treatment.

Our first applications were in the treatment of deep breaks in the skin, such as the nasolabial folds. Over time, the laboratories developed more highly cross-linked acids, such as Voluma®, to restore facial volumes.

Hyaluronic acid soon emerged as the treatment of choice for its durability. Injected into a particularly muscular, mobile area such as the nasolabial fold, the product lasts 6 to 8 months. Injected directly against the bone, in the cheekbone or under the eye for example, where there is less movement, the result lasts 4 to 5 years, and may even be long-lasting.

With the development of hyaluronidase, which acts as an antidote, it has at last become possible to change one’s mind or to correct over-injection. No more anxiety, regret or unpleasant surprises. Today we work with a pencil and correct with an eraser.

Every year Allergan® continues to bring aesthetic physicians its latest innovations: volumising gels are less and less hydrophilic. Water retention caused by the acid is greatly reduced and results last longer. Gone, too, is the risk of the Tyndall effect, the bluish discolouration of the injected area caused by poor placement of the product.

For the past 20 years I have worked exclusively with the following acids: Juvéderm® ULTRA 2, ULTRA 3, Voluma® and Volbella®, as well as all the products in the Surgiderm® range.

Over the years I have refined my injection technique, combining dermal filler to restore soft-tissue volume with Botox to rest the muscle responsible for the wrinkle.

This combination of products provides a tailor-made solution for all my patients who wish to look younger in the most natural way possible.

This page is for information. It does not replace a consultation: every situation is judged on examination.

Read more

The full text by Dr Hayot

The detailed version published on the site, kept in full. Each chapter unfolds.

Introduction
In 1986, I learned about the work of optician Waldemar Kita, who had just set up Cornéal, a company specializing in the design and manufacture of intraocular lenses for this delicate surgery. In addition to ophthalmology, Cornéal gradually made its mark in aesthetic medicine with the production of high-quality hyaluronic acid: Juvéderm® and Surgiderm®. As my interest in aesthetic medicine and anti-aging treatments grew, so did my interest in using hyaluronic acid-based products to replace collagen. The risk of allergies was significantly reduced, as the product proved to be much better tolerated by the body. Being resorbable and biodegradable, it also had the advantage of preventing any lasting, irremediable accident. In 2006, Allergan, a pharmaceutical company whose flagship product was botox, acquired the Cornéal laboratory, specializing in injectable products for aesthetic medicine. Product industrialization and marketing took off in the 2000s. As an Allergan referral physician myself, I was asked to test the product in the first cases of wrinkle treatment. Our first applications were in the treatment of deep skin breaks such as nasolabial folds. Over time, laboratories developed more polymerized acids - such as Voluma® - to restore facial volumes. Hyaluronic acid soon emerged as the treatment of choice for its durability. Injected into a particularly muscular, active area such as the nasolabial fold, the product lasts 6 to 8 months. Injected directly in contact with the bone, in the cheekbone or under the eye, for example, which are areas less subject to mimicry, the result lasts 4 to 5 years - and may even be long-lasting. On the other hand, with the development of hyaluronidase, which works like an antidote, changing one's mind or correcting "over-injections" has finally become possible. No more anxieties, regrets or unpleasant surprises! Today, we work with a pencil and correct with an eraser. Every year, Allergan® continues to provide aesthetic physicians with their latest innovations: volumetric gels are less and less hydrophilic. Acid-induced water retention is greatly reduced, and results last longer. Gone, too, are the risks of the Tyndall effect (bluish discoloration of the injected area due to poor product placement)! For the past 20 years, I've been working exclusively with the following acids: Juvederm® ULTRA 2, ULTRA 3, Voluma® and Volbella® as well as all the products in the Surgiderm® range. Over the years, I've perfected my injection technique, combining dermal filler to restore soft tissue volume with Botox to rest the muscle responsible for wrinkles. This combination of products provides a tailor-made solution for all my patients who want to rejuvenate in the most natural way possible.